製薬
Interest is growing in model driven architecture (MDA) Agile programming whereby a platform independent model is first developed. As a result of regulatory filing requirements and the need to protect against litigation, the Pharmaceutical industry records and saves data that must be reconstituted for subsequent filing submittal or Batch release (Electronic batch records). A model developed in the pilot lab and used as the guideline for manufacturing scale up, can aid filing submittal.